 T-Cell Antigen Receptor Specificity
"T-Cell Antigen Receptor Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The property of the T-CELL RECEPTOR which enables it to react with some antigens and not others. The specificity is derived from the structure of the receptor's variable region which has the ability to recognize certain antigens in conjunction with the MAJOR HISTOCOMPATIBILITY COMPLEX molecule.
| Descriptor ID |
D037182
|
| MeSH Number(s) |
G12.450.900
|
| Concept/Terms |
T-Cell Antigen Receptor Specificity- T-Cell Antigen Receptor Specificity
- T Cell Antigen Receptor Specificity
- T-Cell Receptor Specificity
- Specificity, T-Cell Receptor
- T Cell Receptor Specificity
T-Cell Specificity- T-Cell Specificity
- Specificity, T-Cell
- T Cell Specificity
- T-Cell Immunologic Specificity
- Immunologic Specificity, T-Cell
- Specificity, T-Cell Immunologic
- T Cell Immunologic Specificity
|
Below are MeSH descriptors whose meaning is more general than "T-Cell Antigen Receptor Specificity".
Below are MeSH descriptors whose meaning is more specific than "T-Cell Antigen Receptor Specificity".
This graph shows the total number of publications written about "T-Cell Antigen Receptor Specificity" by people in UAMS Profiles by year, and whether "T-Cell Antigen Receptor Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 1 | 1 | 2 | | 2017 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "T-Cell Antigen Receptor Specificity" by people in Profiles over the past ten years.
-
Zhou X, Rasche L, Kort?m KM, Danhof S, Hudecek M, Einsele H. Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies. Front Immunol. 2020; 11:620312.
-
Lund ME, Howard CB, Thurecht KJ, Campbell DH, Mahler SM, Walsh BJ. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020 Dec 10; 20(1):1214.
-
Lu YC, Zheng Z, Robbins PF, Tran E, Prickett TD, Gartner JJ, Li YF, Ray S, Franco Z, Bliskovsky V, Fitzgerald PC, Rosenberg SA. An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors. Mol Ther. 2018 02 07; 26(2):379-389.
-
Yao X, Lu YC, Parker LL, Li YF, El-Gamil M, Black MA, Xu H, Feldman SA, van der Bruggen P, Rosenberg SA, Robbins PF. Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy. J Immunother. 2016 06; 39(5):191-201.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|